Development of a Novel [ 11 C]CO-Labeled Positron Emission Tomography Radioligand [ 11 C]BIO-1819578 for the Detection of O -GlcNAcase Enzyme Activity
ACS Chemical Neuroscience · 2023
DOI: 10.1021/acschemneuro.3c00247 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von Sangram Nag und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm 17176, Sweden. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Brain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biogen.
Abstract (Originalsprache)
Imaging O-GlcNAcase OGA by positron emission tomography (PET) could provide information on the pathophysiological pathway of neurodegenerative diseases and important information on drug-target engagement and be helpful in dose selection of therapeutic drugs. Our aim was to develop an efficient synthetic method for labeling BIO-1819578 with carbon-11 using 11CO for evaluation of its potential to measure levels of OGA enzyme in non-human primate (NHP) brain using PET. Radiolabeling was achieved in one-pot via a carbon-11 carbonylation reaction using [11C]CO. The detailed regional brain distribution of [11C]BIO-1819578 binding was evaluated using PET measurements in NHPs. Brain radioactivity was measured for 93 min using a high-resolution PET system, and radiometabolites were measured in monkey plasma using gradient radio HPLC. Radiolabeling of [11C]BIO-1819578 was successfully accomplished, and the product was found to be stable at 1 h after formulation. [11C]BIO-1819578 was characterized in the cynomolgus monkey brain where a high brain uptake was found (7 SUV at 4 min). A pronounced pretreatment effect was found, indicating specific binding to OGA enzyme. Radiolabeling of [11C]BIO-1819578 with [11C]CO was successfully accomplished. [11C]BIO-1819578 binds specifically to OGA enzyme. The results suggest that [11C]BIO-1819578 is a potential radioligand for imaging and for measuring target engagement of OGA in the human brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm 17176, Sweden.
- BIOGEN MA Inc., 225 Binney St., Cambridge, Massachusetts 02142, United States.
ORCID-Profile: Sangram Nag, Edward Lin
Förderung
- Biogen
Zitieren
APA
Nag, S., Bolin, M., Datta, P., Arakawa, R., Forsberg Morén, A., Khani Maynaq, Y., Lin, E., Genung, N., Hering, H., Guckian, K., Martarello, L., Kaliszczak, M., & Halldin, C. (2023). Development of a Novel [ 11 C]CO-Labeled Positron Emission Tomography Radioligand [ 11 C]BIO-1819578 for the Detection of O -GlcNAcase Enzyme Activity. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00247
Vancouver
Nag S, Bolin M, Datta P, Arakawa R, Forsberg Morén A, Khani Maynaq Y, et al. Development of a Novel [ 11 C]CO-Labeled Positron Emission Tomography Radioligand [ 11 C]BIO-1819578 for the Detection of O -GlcNAcase Enzyme Activity. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00247
BibTeX
@article{Nag2023,
author = {Nag, Sangram and Bolin, Martin and Datta, Prodip and Arakawa, Ryosuke and Forsberg Morén, Anton and Khani Maynaq, Yasir and Lin, Edward and Genung, Nathan and Hering, Heike and Guckian, Kevin and Martarello, Laurent and Kaliszczak, Maciej and Halldin, Christer},
title = {Development of a Novel [ 11 C]CO-Labeled Positron Emission Tomography Radioligand [ 11 C]BIO-1819578 for the Detection of O -GlcNAcase Enzyme Activity},
journal = {ACS Chemical Neuroscience},
year = {2023},
doi = {10.1021/acschemneuro.3c00247}
}
EUVIMED